Rapid construction of adenoviral vectors by lambda phage genetics

Area of Science:

• Molecular Biology
• Virology
• Genetic Engineering

Background:

• Adenoviral vectors are crucial for gene therapy and require novel genome configurations for improved efficacy.
• Current methods for adenoviral genome construction and virus production are often intertwined, complicating the generation of modified genomes.
• Separating genome construction from virus production allows for independent optimization and troubleshooting.

Purpose of the Study:

• To develop a novel, rapid, and efficient system for modifying adenoviral genomes.
• To enable the creation of diverse adenoviral vector configurations for research and therapeutic applications.
• To facilitate the investigation of novel adenoviral genome structures independent of virus production limitations.

Main Methods:

• A lambda-based system utilizing double homologous recombination in Escherichia coli was developed.
• The system involves homologous recombination between an adenovirus cosmid and a donor plasmid carrying desired modifications.
• In vivo lambda packaging, transduction of recombination-deficient E. coli, and selection for double-recombinant cosmids are key steps.

Main Results:

• The system allows for rapid modification of adenoviral genomes independent of restriction endonucleases.
• High yields of correctly modified double-recombinant cosmids (approx. 10,000 per reaction) were achieved.
• Adenoviral genomes deficient in E1/E3 and E1/E3/E4 regions were successfully generated quickly and efficiently.

Conclusions:

• The developed lambda-based system provides a robust platform for efficient adenoviral genome engineering.
• This technology facilitates the rapid generation and investigation of novel adenoviral vector configurations.
• The system's independence from restriction enzymes and its high efficiency make it valuable for advancing adenoviral vector development.